Uncategorized

These 10 Stocks Could Be the Market’s Biggest Winners in January

When investors sell their stocks at year-end, it has nothing to do with whether they like the company or if they believe a turnaround is coming. Instead, it has everything to do with taxes.

These Health-Tech Deals Highlight a Big Private Investing Trend

Most of Google's products have been built up by acquiring companies that fill its blind spots. Biotech companies are doing the same thing.

Upstart Holdings Is Destined To Revisit Its All-Time High

A return to $400 and beyond is the most probable outcome for UPST stock as this audacious fintech disruptor stands on firm financial ground.

Don’t Follow “Dumb Money” Into This Corner of the Crypto Market

Investment firms are pouring more money than ever into the blockchain, but those investments differ from traditional crypto in a key way.

The $7 TRILLION Self-Driving Revolution Is Here

For years, self-driving cars have been a mere science fiction concept with very rare on-road testing. Now, they’re ready to take over the world? What happened!? I’ll tell you what changed: The cost of LiDAR technology.

Weekly Upgrades and Downgrades

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 89 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters

Genfit (GNFT) stock is rocketing higher on Friday after the company signed an exclusive licensing agreement with Ipsen (IPSEY).

What This Crypto Billionaire’s Big Bet on Longevity Means for You

Our lifespans have been on the rise for a century. The CEO of Coinbase is one person looking to expand our healthspans as well.

Are You Taking “Good Risk” or “Bad Risk”?

The Fed is between a rock and a hard place … a tough place to begin hiking rates … why it’s not time to get…

Against Any Odds…Here’s How to Succeed in 2022

Our trio of Wall Street analysts put together our stock market playbook for next year, and you don't want to miss it.

Healthcare Startups Are Raking in Cash… and the Trend Is Just Starting

Healthcare is not only improving our lifespans, but also our healthspans, the period of time when we're at our best physically and mentally.

Weekly Upgrades and Downgrades

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 91 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

What Does The Metaverse Mean For Non-Gamers?

But outside of gaming, there are plenty of applications for Metaverse technologies. Add them all up, and you start to see how the Metaverse could become worthy of the hype – and why investors should take notice. Let’s look at a few now.

AMC Stock Could Be In the Teens by This Time Next Year 

AMC stock has a lot working against it, including valuation, trading history, share sales and a lack of free cash flow generation.

Trend Alert! Money Is Pouring Into Private Blockchain Companies

The development of cryptocurrency infrastructure is a trend too big to ignore. Private companies are innovating in this important new space.

Private Investment Bubble Spells Huge Opportunity

IPOs are bigger than they've been in years, but early-stage investing is at a low. That's a big opportunity worth monitoring closely.

Weekly Upgrades and Downgrades

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 115 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

Buy? Sell? Hold?

Markets feel increasingly bipolar … the right action plan … a special event with three of our top analysts   “Do I sell now and…

Two Technologies… One Massive Disruption

Quantum computing and artificial intelligence are closer than you think. Pay attention to up and coming companies focused on these fields.